Results 51 to 60 of about 97,768,553 (154)
Modulation of Animal Gut Health by Milk Oligosaccharide
This review summarizes the composition and structural characteristics of MOs across different mammalian species, and elucidates their roles and mechanisms in maintaining intestinal homeostasis by regulating gut microbiome and enhancing intestinal chemical, physical and immune barriers.
Ningtao Chen +7 more
wiley +1 more source
Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice [PDF]
The oligosaccharides 2-fucosyllactose and 3-fucosyllactose are major constituents of human breast milk but are not found in mouse milk. Milk oligosaccharides have a prebiotic action, thus affecting the colonisation of the infant intestine by microbiota ...
Hennet, Thierry +2 more
core
Precision fermentation uses engineered microorganisms to produce targeted food ingredients, including proteins, enzymes, lipids, flavors, vitamins, and bioactives. This review examines its technological foundations, food applications, safety, sustainability, economics, regulation, and consumer acceptance, emphasizing that performance depends on host ...
Nora Ali Hassan +2 more
wiley +1 more source
HPAEC-PAD analysis of RgGH98 against fucosylated oligosaccharides and polysaccharides.
2′FL (A), 3FL (B), DFL (C), Fucα1,6GlcNAc (D, the upper panel is with RgGH98 and the lower panel is with SpGH98), xyloglucan (E), arabinoxylan (F).
Daniel I. R. Spencer (7470782) +18 more
core +1 more source
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley +1 more source
2’-Fucosyllactose (2’-FL) shows the potential to support intestinal health as a natural prebiotic that bridges the gap between infant formula feeding and breastfeeding.
Qingxue Chen +9 more
doaj +1 more source
Gut microbiota as a novel therapeutic target for eating disorders and obesity
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė +5 more
wiley +1 more source
Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal [PDF]
A number of bifidobacterial species are found at a particularly high prevalence and abundance in faecal samples of healthy breastfed infants, a phenomenon that is believed to be, at least partially, due to the ability of bifidobacteria to metabolize ...
van Sinderen, Douwe +17 more
core +1 more source
Safety of lacto‐N‐fucopentaose I/2’‐fucosyllactose (LNFP‐I/2’‐FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283 [PDF]
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on lacto-N-fucopentaose I (LNFP-I)/2′-fucosyllactose (2’-FL) mixture as a novel food (NF) pursuant to ...
Hirsch-Ernst K. I. +92 more
core +1 more source
2’-Fucosyllactose (2’−FL), a predominant human milk oligosaccharide, plays a crucial role in the development of the infant gut microbiota and immune system.
Ce Qi +16 more
doaj +1 more source

